Shopping Cart
Remove All
Your shopping cart is currently empty
BML-286 is a WNT pathway modulator with potential anticancer activity, inducing β-catenin- and TCF-dependent transcriptional activity, and can be used in the study of degenerative diseases, intestinal, breast, bladder, gastric, melanoma, leukemia, hepatocellular carcinoma and nephroblastoma.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $32 | In Stock | In Stock | |
| 5 mg | $73 | In Stock | In Stock | |
| 10 mg | $118 | In Stock | In Stock | |
| 25 mg | $239 | In Stock | In Stock | |
| 50 mg | $355 | In Stock | In Stock | |
| 100 mg | $526 | - | In Stock | |
| 200 mg | $748 | - | In Stock |
| Description | BML-286 is a WNT pathway modulator with potential anticancer activity, inducing β-catenin- and TCF-dependent transcriptional activity, and can be used in the study of degenerative diseases, intestinal, breast, bladder, gastric, melanoma, leukemia, hepatocellular carcinoma and nephroblastoma. |
| Targets&IC50 | Wnt pathway-dependent PC3 cells:12.5 μM, PDZ structural domain of Dishevelled protein:10.6 μM (Kd) |
| In vitro | BML-286 (Compound 3289-8625) inhibits the Wnt signaling pathway by binding to the PDZ structural domain of Dishevelled (Dvl) protein (Kd = 10.6 μM). In addition, BML-286 blocked Wnt3a-induced transcriptional activity and effectively inhibited the growth of Wnt pathway-dependent prostate cancer PC-3 cells in vitro (IC50 = 12.5 μM). [1] |
| Synonyms | BML286 |
| Molecular Weight | 374.39 |
| Formula | C22H18N2O4 |
| Cas No. | 294891-81-9 |
| Smiles | O=C(O)C=1C=CC=CC1NC(=O)C=2C=CC=C(C2)NC(=O)CC=3C=CC=CC3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.